examined the expression of TIM-3 protein on tumor cells and TILs in 123 patients with DLBCL.39% of DLBCL patients showed positive TIM-3 in tumor cells, and patients with high expression of TIM-3 in TILs had a poor prognosis (12). This evidence concerns the gene HAVCR2 and diffuse large B-cell lymphoma.